Logo

U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com

Last Updated: 17.06.2025 00:19

U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com

RAHWAY, N.J.--(BUSINESS WIRE)--

June 9, 2025 3:11 pm ET

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has ap… [+11553 chars]

Artists get better with age, e.g., painting. Yet when it comes to pop music, the famous work tends to be written when musicians are in their twenties. So, why aren't Bob Dylan or the Stones banging out amazing tunes now?